BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3809694)

  • 1. [Value of mazindol in Gélineau's disease. Apropos of 10 cases].
    Vespignani H; Weber M; Atlas P; Barroche G
    Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):317-22. PubMed ID: 3809694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of mazindol on narcolepsy.
    Iijima S; Sugita Y; Teshima Y; Hishikawa Y
    Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mazindol in the treatment of narcolepsy.
    Parkes JD; Schachter M
    Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine, mazindol, and fencamfamin in narcolepsy.
    Shindler J; Schachter M; Brincat S; Parkes JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the psychopharmacological management of the narcoleptic patient].
    Salín-Pascual RJ; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of mazindol in the treatment of narcolepsy.
    Vespignani H; Barroche G; Escaillas JP; Weber M
    Sleep; 1984; 7(3):274-5. PubMed ID: 6484432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 9. Mazindol in long-term treatment of narcolepsy.
    Alvarez B; Dahlitz M; Grimshaw J; Parkes JD
    Lancet; 1991 May; 337(8752):1293-4. PubMed ID: 1674093
    [No Abstract]   [Full Text] [Related]  

  • 10. Mazindol for nocturnal enuresis.
    Tiptaft RC; Woodhouse CR; Badenoch DF
    Br J Urol; 1984 Dec; 56(6):641-3. PubMed ID: 6534482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
    Evans ER; Wallace MG
    Curr Med Res Opin; 1975; 3(3):132-7. PubMed ID: 1149481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mazindol in the control of micturition.
    Woodhouse CR; Tiptaft RC
    Br J Urol; 1983 Dec; 55(6):636-8. PubMed ID: 6360295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
    Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
    Zatz M; Rapaport D; Pavanello RC; Rocha JM; Vainzof M; Nicolau W
    Am J Med Genet; 1989 Aug; 33(4):457-67. PubMed ID: 2596504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selegiline in narcolepsy.
    Roselaar SE; Langdon N; Lock CB; Jenner P; Parkes JD
    Sleep; 1987 Oct; 10(5):491-5. PubMed ID: 3120270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Narcolepsy].
    Lange KW
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1244-50. PubMed ID: 2201510
    [No Abstract]   [Full Text] [Related]  

  • 20. Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
    Kales A; Cadieux RJ; Soldatos CR; Bixler EO; Schweitzer PK; Prey WT; Vela-Bueno A
    Arch Neurol; 1982 Mar; 39(3):164-8. PubMed ID: 7065934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.